Lars Thomander
Corporate Officer/Principal en University of Uppsala .
Cargos activos de Lars Thomander
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Uppsala | Corporate Officer/Principal | - | - |
Historial de carrera de Lars Thomander
Antiguos cargos conocidos de Lars Thomander.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Abbott Scandinavia AB | Director Técnico/Científico/I+D | 01/01/2009 | 01/01/2013 |
AbbVie AB
 AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Director Técnico/Científico/I+D | 01/01/2009 | 01/01/2013 |
| ELI LILLY AND COMPANY | Director Técnico/Científico/I+D | - | - |
| Foundation for Pharmaceutical Medicine | Director/Miembro de la Junta | - | - |
| Swedish Pharmaceutical Society | Presidente | - | - |
| Hlt Konsult AB | Director/Miembro de la Junta | - | - |
| Fundador | - | - | |
CaptiGel AB
 CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Presidente | 01/01/2014 | - |
Double Bond Pharmaceutical International AB
 Double Bond Pharmaceutical International AB BiotechnologyHealth Technology Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden. | Director/Miembro de la Junta | 01/04/2015 | - |
Estadísticas
Internacional
| Suecia | 9 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chairman | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
 | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Empresas privadas | 6 |
|---|---|
CaptiGel AB
CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |
| Hlt Konsult AB | |
| Abbott Scandinavia AB | |
AbbVie AB
AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Commercial Services |
| Swedish Pharmaceutical Society | |
| Foundation for Pharmaceutical Medicine |
- Bolsa de valores
- Insiders
- Lars Thomander
- Experiencia
